{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T13:28:20Z","timestamp":1745328500146},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hepatosplenic T-cell lymphoma (HSTCL) is a rare but aggressive type of peripheral T-cell lymphoma (PTCL). There is an urgent need for effective treatment due to the poor prognosis of HSTCL. Here, for the 1st time we describe the rare successful case of HSTCL who relapsed after a previous allogeneic stem-cell transplantation (allo-SCT), achieved remission with the second allo-SCT from the same donor.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 24-year-old male, presented with a 2-week history of fever, drenching night sweats and nonquantified weight loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Laboratory studies, flow cytometry of immunophenotyped, and physical examination results strongly suggested hepatosplenic \u03b3\/\u03b4 T-cell lymphoma, stage IVB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>We proceeded to an allo-SCT with a human leukocyte antigen (HLA) identical sibling donor. The bone marrow examination and fluorescent in situ hybridization were observed for complete donor chimerism of bone marrow cells on day 34. On day 157 after the initial allo-SCT, the bone marrow examination revealed the relapse of the sinusoidal infiltration with lymphoma cells. Considering the disease persistence, we conducted the second allo-SCT from the same HLA-identical sibling donor immediately.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Bone marrow examination indicated hematologic recovery without residual lymphoma cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Our encouraging outcome suggests that the latter allo-SCT needs to be considered early for patients with disease recurrence, and it also demonstrates that graft-vs-lymphoma conferred by allo-SCT may play an essential role on HSTCL treatment. Furthermore, detecting related genes at diagnosis may have prognostic implications and guidance value for personal chemotherapy program.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000012941","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T23:41:29Z","timestamp":1541029289000},"page":"e12941","source":"Crossref","is-referenced-by-count":5,"title":["Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (\u03b3\/\u03b4) T-cell lymphoma"],"prefix":"10.1097","volume":"97","author":[{"given":"Hui","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Blood Rheumatology, The Sixth People's Hospital of Chengdu, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Song","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2014.280","article-title":"Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party","volume":"29","author":"Tanase","year":"2015","journal-title":"Leukemia"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1080\/10428190310001609924","article-title":"Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha\/beta hepatosplenic T-cell non-Hodgkin's lymphoma","volume":"45","author":"Chanan-Khan","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","article-title":"Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience","volume":"13","author":"Voss","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1600-0463.2008.00974.x","article-title":"Immunohistochemical expression of multidrug resistance proteins in mature T\/NK-cell lymphomas","volume":"116","author":"Saglam","year":"2008","journal-title":"APMIS"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jcla.21563","article-title":"Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy","volume":"27","author":"de Moraes","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/10428194.2014.947613","article-title":"Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma","volume":"56","author":"Sumi","year":"2015","journal-title":"Leukemia Lymphoma"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1182\/blood-2011-12-396150","article-title":"Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets","volume":"119","author":"Travert","year":"2012","journal-title":"Blood"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1182\/blood-2010-03-274506","article-title":"Mutation of inhibitory helix-loop-helix protein Id3 causes gammadelta T-cell lymphoma in mice","volume":"116","author":"Li","year":"2010","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811020-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:17:36Z","timestamp":1694715456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811020-00021"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":11,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012941","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}